Hypothalamic & Pituitary Hormones Flashcards

0
Q

Receptor for GH and prolactin?

A

JAK/STAT superfamily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Drugs that mimic or block the effects of hypothalamic and pituitary hormones have pharmacologic applications in three main areas:

A
  1. Replacement therapy for hormone deficiency states
  2. Antagonist for diseases that result from excess production of hormones
  3. Diagnostic tools for identifying endocrine abnormalities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

GPCRs are receptors for what hormones?

A
  1. TSH
  2. FSH
  3. LH
  4. ACTH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

GH, somatotropin

  1. Hypothalamic hormone?
  2. Target organs?
  3. Primary target organ hormone or mediator?
A
  1. GHRH (+), stomatostatin (-)
  2. liver, muscle, bone, kidney, and others
  3. insulin-like growth factor 1 (IGF-1)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

TSH

  1. Hypothalamic hormone?
  2. Target organs?
  3. Primary target organ hormone or mediator?
A
  1. TRH (+)
  2. thyroid
  3. thyroxine, triiodothyronine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Adrenocorticotropin (ACTH)

  1. Hypothalamic hormone?
  2. Target organs?
  3. Primary target organ hormone or mediator?
A
  1. CRH (+)
  2. adrenal cortex
  3. glucocorticoids, mineralcorticoids, androgens
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Follicle-stimulating (FSH) and Luteinizing hormone (LH)

  1. Hypothalamic hormone?
  2. Target organs?
  3. Primary target organ hormone or mediator?
A
  1. GnRH (+)
  2. gonads
  3. estrogen, progesterone, testosterone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Prolactin (PRL)

  1. Hypothalamic hormone?
  2. Target organs?
  3. Primary target organ hormone or mediator?
A
  1. dopamine (-)
  2. breast
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Growth Hormone (somatotropin)

Pharmacodynamics?

A

mediates effects via cell surface receptors that activate JAK/STAT signaling cascades.

binds to two tyrosine receptors -> dimerizes -> self phosphorylate -> signaling cascade -> upregulate genes
(slow effect b/c requires gene expression)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Growth Hormone (somatotropin)

Physiological effects?

A
  1. stimulation of longitudinal growth of bones
  2. increased bone mineral density
  3. increased muscle mass (in GH deficient people)
  4. increased GFR
  5. stimulation of preadipocyte differentiation into adipocytes
  6. anti-insulin actions (decreased glucose utilization and increased lipolysis)
  7. development and increased function of immune system
    7.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Growth Hormone (somatotropin)

Clinical pharmacology?

A
  1. Growth hormone deficiency
    - genetic or damage to pituitary or hypothalamus
    - short stature and adiposity (in children)
    - hypoglycemia (unopposed insulin action)
  2. criteria for diagnosis
    - a growth rate < 4cm per year
    - the absence of a serum GH response to two GH secretagogoues.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Growth Hormone (somatotropin)

recombinant form?

A
  1. somatropin = recombinant GH

2. somatrem = GH analog

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Growth Hormone (somatotropin)

clinical condition?

A
  • Growth failure in pediatric pts associated with:
    1. GH deficiency
    2. chronic failure
    3. noonan syndrome
    4. Prader-Willi syndrome
    5. short stature homeobox-containing gene deficiency
    6. Turner syndrome
    7. small for gestational age with failure to catch up by age 2
    8. idiopathic short stature in pediatric pts
  • Growth hormone deficiency in adults
  • wasting in HIV + pts
  • short bowel syndrome in pts who are receiving specialized nutritional support
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Growth Hormone (somatotropin)

Primary therapeutic objective?

A
  • growth
  • Improved metabolic state, increased lean body mass, sense of well-being, weight, and physical endurance
  • improved GI function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Growth Hormone (somatotropin)

Adverse effects in children?

A
  • scoliosis (during rapid growth)
  • hypothyroidism
  • intracranial HTN
  • otitis media (increased risk for turner)
  • pancreatitis, gynecomastia, nevus growth
  • diabetic syndrome (chronic use)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Growth Hormone (somatotropin)

Adverse effect in adults?

A
  • peripheral edema, myalgias and arthralgias (hands/wrists)
  • carpal tunnel syndrome
  • proliferative retinopathy (rare)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Growth Hormone (somatotropin)

Contraindications?

A

CYP450 inducer

patients with a known malignancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

IGF-1 Analog - mecasermin

uses?

A
  • IGF-1 deficiency in children

- causes: mutations in gene that encodes for GH receptor and development of neutralizing antibodies to GH.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

IGF-1 Analog - mecasermin

Adverse effects?

A
  • hypoglycemia (eat 20min before or after admin)
  • intracranial HTN
  • asx elevation of liver enzymes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

sx’s of GH secreting tumors?

A
  • commonly in adults
  • sx’s:
    1. acromegaly (abnl growth of cartilage, bone tissue, skin, muscle, heart, liver and GI tract)
    2. giantism (if occurs before long bone epiphyses close)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

GH hormone secreting tumors - tx?

A

GH antagonists for small adenomas:

  1. GH receptor antagonists
  2. somatostatin analogs
  3. dopamine receptor agonists

Large adenomas require surgery or radiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Pegvisomant?

A

GH receptor antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Octreotide?

A

somatostatin analog.

inhibits release of GH, TSH, glucagon, insulin, and gastrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Octreotide

Pharmacokinetics?

A

45x more potent in inhibiting GH release than somatostatin

Octreotide acetate = long-acting suspension can be given at 4 week intervals.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Octreotide

Clinical applications?

A

reduces sx’s caused by hormone-secreting tumors

localizing neuroendocrine tumors

acute control of bleeding from esophageal varices.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Octreotide

Adverse effects?

A

nausea, vomiting, abd cramps, flatulence, steatorrhea

constipation

biliary sludge and gallstones

sinus bradycardia and conduction distubances

vit B12 deficiency

pain at injxn site = common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Bromocriptine and Cabergoline?

A

dopamine agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Bromocriptine and Cabergoline

Clinical applications?

A
  1. adenomas that secrete excess prolactin
  2. hyperprolactinemia (standard tx)
  3. acromegaly (alone or in addition to surgery, radiation or octreotide)
28
Q

Bromocriptine and Cabergoline

Adverse effects?

A

nausea (bromocriptine > cabergolien), HA, light-headedness, orthostatic hypotension, fatigue

psychiatric manifestations occasionally occur

high doses = cold-induced peripheral digital vasospasm

chronic high-dosage therapy = pulmonary infiltrates

29
Q

what are some gonadotropins?

A
  1. FSH
  2. LH
  3. hCG
30
Q

what are the effects of FSH and LH in women?

A

FSH: ovarian follicle devel
FSH and LH: ovarian steroidogenesis

Luteal stage of mens cycle: estrogen/progesterone production is primary under control of LH.
during pregnancy hCG takes over.

31
Q

what are the effects of FSH and LH in men?

A

FSH: spermatogenesis, conversion of testosterone to estrogen. maintains high local androgen conc in vicinity of devel cells

LH: stimulus for production of testosterone

32
Q

gonadotropins

Clinical applications?

A

Infertility: stimulating spermatogenesis in men & induce ovulation in women (IVF)

33
Q

Menotropins?

A

Aka menopausal gonadotropins

Purified extract of FSH and LH

34
Q

Follitropin and urofollitropin?

A

Purified FSH

Follitropn alpha & follitropin beta (rFSH): recombination FSH
Urofollitropin (uFSH): purified human FSH extract

35
Q

Human chorionic gonadotropin (hCG)?

A
Extracted and purified from urine (given IM) 
Choriogonadotropin alpha (rhCG): recombinant form (given SC)
36
Q

Gonadotropins

Clinical applications?

A
  • ovulating induction: when other tx’s don’t work
  • male infertility:
    Hypogonadal men require both FSH and LH. Tx can consists of 1. hCG alone 2. Alt protocols using urofollitropin, rFSH, and rLH
37
Q

gonadotropins

Adverse effects in men and women?

A

Men:
Gynecomastia

Women:
Ovarian hyperstimulation syndrome
Multiple pregnancies
HA, depression, edema, precocious puberty

38
Q
  1. What is the name of the synthetic gonadotropin-releasing hormone?
  2. What are some gonadotropin -releasing hormone analogs?
A
  1. gonadorelin
  2. goserelin, leuprolide, nafarelin
    - more potent and longer lasting than gonadorelin
39
Q

describe GnRH and it’s sustained administration…

A

binds to GPCRs on gonadotroph cell membranes.
pulsatile secretion - required to stimulate release of LH and FSH.

sustained non-pulsatile admn of GnRH inhibits FSH and LH release (men and women) leading to hypogonadism

40
Q

GnRH and analogs

Pharmacokinetics?

A

gonadorelin = IV or SC.

goserelin, leuprolide, nafarelin = SC, IM, nasal spray (nafarelin) or as SC implant.

41
Q

GnRH and analogs

Administration?

A

continous administration gives biphasic response:

  1. first 7 days = agonist response “flare”
  2. chronic effects (>1wk) = inhibitory action (d/t receptor down-regulation & changes in signaling pathways)
42
Q

GnRH and analogs

Stimulation?

A

female infertility: use is uncommon (inconvenient & costly)

male infertility: in men c hypothalamic hypogonadotropic hypogonadism (pulsatile gonadorelin)

diagnostic of LH responsiveness: whether delayed puberty is d/t constitutional delay or hypogandotropic hypogonadism.

43
Q

GnRH and analogs

Suppression?

A

controlled ovarian hyperstimulation (leuprolide, nafarelin): critical to suppress endogenous LH surge that could prematurely trigger ovulation.

endometriosis (leuprolide, goserelin, nafarelin): pain often decreased by abolishing exposure to cyclical changes in estrogen & progesterone conc during mens cycle, tx limited to 6mos.

uterine leiomyomata (fibroids) (leuprolide, goserelin, nafarelin): can reduce fibroid size and combined c suppl iron can improve anemia.

prostate cancer (leuprolide, goserelin): combined therapy c continuous GnRH agonist and an androgen receptor antagonist is effective as castration in reducing serum testosterone.

central precocious puberty (leuprolide, nafarelin): must confirm dx before tx begins

advanced breast and ovarian cancer

tx of amenorrhea & infertility in women c polycystic ovarian disease

thinning of endometrial lining: preparation for endometrial ablation procedure in women c dysfunctional uterine bleeding.

44
Q

Gonadorelin

Adverse effects?

A
  • HA, light-headedness, nausea, flushing
  • swelling of SC injxn site
  • Generalized hypersensitivity dermatitis (long-term admin)
  • Rare acute hypersensitivity rxns.
  • Sudden pituitary apoplexy & blindness (pts c gonadotropin-secreting pituitary tumor)
45
Q

Goserelin, leuprolide, nafarelin

adverse effects in women and men?

A

women:
- menopausal sx’s (hot flushes, sweats, HA)
- depression, diminished libido, generalized pain, vaginal dryness & breast atrophy
- ovarian cysts
- reduced bone density

men:
hot flushes, sweats, edema, gynecomastia, decreased libido, decreased hematocrit, reduced bone density, asthenia, injxn site rxns.

46
Q

Goserelin, leuprolide, nafarelin

contraindications?

A

pregnant and breast-feeding women

47
Q

Name the GnRH receptor antagonists?

A

cetrorelix

ganirelix

48
Q

cetrorelix, ganirelix

clinical applications?

A

suppression of gonadotropin production: prevent LH surge during controlled ovarian hyperstimulation.

49
Q

Name the ACTH hormone analogs?

A

corticotropin

cosyntropin

50
Q

why is ACTH analogs less use?

A

limited utility as a therapeutic agents (less predictable and convenient than corticosteroid therapy)

51
Q

corticotropin, cosyntropin

pharmacodynamics and features?

A
  • act via MC2R (GPCR -> increased cAMP) to stimulate adrenal cortex to secrete glucocorticoids, mineralcorticoids and androgen precursor.
  • ACTH normally released from pituitary in pulses c highest conc at 6am and lowest in evening. secretion also stimulation by stress.
  • cortisol suppresses its release (-ve feedback)
52
Q

corticotropin, cosyntropin

clinical applications?

A

diagnostic tool for differentiating b/w primary adrenal insufficiency (addison’s disease) and secondary adrenal insufficiency (inadequate ACTH secretion)

Infantile spasm (West syndrome) tx

53
Q

name the posterior pituitary hormones?

A

antidiuretic hormone

oxytocin

54
Q

oxytocin

pharmacodynamics?

A

acts on GPCRs -> stimulates release of prostaglandins and leukotrienes that augment uterine contraction

small doses - increase force and frequency of contractions

higher doses - evoke sustained contractions. weak antidiuretic and pressor activity (vasopressin R activation)

contraction of myoepithelial cells surrounding mammary alveoli -> milk ejection.

55
Q

Oxytocin

Pharmacokinetics?

A

IV used for initiation and augmentation of labor

IM used for control of postpartum bleeding

56
Q

oxytocin

clinical applications?

A

labor induction: when early vaginal delivery is required (Rh problems, maternal diabetes, preeclampsia, ruptured membranes)

augment normal labor: when labor is protracted or displays arrest disorder

control of uterine hemorrhage

57
Q

oxytocin

Adverse effects?

A

excessive stimulation of uterine contractions: fetal distress, placental abruption, uterine rupture

inadvertent activation of vasopression receptors: excessive fluid retention, water intoxication -> hyponatremia, heart failure, seizures, death

bolus injxns can lead to hypotension: adm IV as dilute sln at a controlled rate.

58
Q

oxytocin

contraindications?

A
fetal distress
prematurity 
abnl fetal presentation
cephalopelvic disproportion
uterine rupture predisposition
59
Q

oxytocin antagonist and it’s tx?

A

Atosiban (not in US)

tx of preterm labor

60
Q

vasopressin (ADH) agonists?

A

vasopressin

desmopressin

61
Q

features of vasopressin?

A

released in response to rising plasma tonicity or falling BP

both antidiuretic & vasopressor activities.

62
Q

vasopressin, desmopressin

pharmacogynamics?

A

2 GPCRs activated

V1R = vascular smooth muscle -> vasoconstriction
V2R = renal tubule cells -> increased water permeability and water reabsorption
63
Q

vasopressin, desmopressin

Pharmacokinetics?

A

vasopressin: IV, IM
desmopressin: IV, SC, intranasally or orally

64
Q

vasopressin, desmopressin

clinical applications?

A

DOC for diabetes insipidus

vasopressin: esophageal variceal bleeding and colonic diverticular bleeding
desmopressin: coagulopathy tx in hemophilia A and von Willebrand’s disease

65
Q

vasopressin, desmopressin

Adverse Effects?

A

HA, nausea, abd cramps, allergic rxns

overdosage = hyponatremia/seizures.

66
Q

vasopressin antagonists?

A

conivaptan

67
Q

conivaptan

clinical use?

A

pts c hyponatremia (d/t elevated vasopressin)

has high affinity for V1 and V2 receptors.